ADMA Biologics Inc
ADMA15.005USD
+0.295+2.01%
交易中 （美东）报价延迟15分钟
3.58B总市值
17.07市盈率 TTM
关于 ADMA Biologics Inc 公司
ADMA Biologics, Inc. 是一家端到端商业生物制药公司，致力于制造、营销和开发用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者的特种生物制剂。该公司制造和营销三种经美国食品药品管理局 (FDA) 批准的血浆衍生生物制剂，用于治疗免疫缺陷和预防某些传染病：BIVIGAM（人静脉注射免疫球蛋白），用于治疗原发性体液免疫缺陷 (PI)；ASCENIV（人静脉注射免疫球蛋白 - slra 10% 液体），用于治疗 PI；NABI-HB（人乙肝免疫球蛋白），用于增强对乙肝病毒的免疫力。通过其子公司 ADMA BioCenters，该公司还在美国经营 FDA 批准的血浆采集者，为其产品制造提供血浆。
ADMA Biologics Inc简介
公司代码ADMA
公司名称ADMA Biologics Inc
上市日期Oct 17, 2013
CEOMr. Adam S. Grossman
员工数量677
证券类型Ordinary Share
年结日Oct 17
公司地址465 State Route 17
城市RAMSEY
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编07446
电话12014785552
网址https://www.admabiologics.com/
公司代码ADMA
上市日期Oct 17, 2013
CEOMr. Adam S. Grossman
ADMA Biologics Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Adam S. Grossman
Mr. Adam S. Grossman
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
3.74M
-0.16%
Dr. Jerrold B. Grossman
Dr. Jerrold B. Grossman
Vice Chairman of the Board, Co-Founder
Vice Chairman of the Board, Co-Founder
570.90K
--
Mr. Brad L. Tade
Mr. Brad L. Tade
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
258.17K
-2.68%
Mr. Lawrence P. Guiheen
Mr. Lawrence P. Guiheen
Independent Director
Independent Director
145.83K
-12.06%
Mr. Steven A. (Steve) Elms
Mr. Steven A. (Steve) Elms
Independent Chairman of the Board
Independent Chairman of the Board
87.33K
--
Mr. Eduardo Rene Salas
Mr. Eduardo Rene Salas
Independent Director
Independent Director
10.89K
--
Dr. Young T. Kwon, Ph.D.
Dr. Young T. Kwon, Ph.D.
Independent Director
Independent Director
--
--
Ms. Alison C. Finger
Ms. Alison C. Finger
Independent Director
Independent Director
--
--
Ms. Kaitlin Kestenberg
Ms. Kaitlin Kestenberg
Chief Operating Officer, Senior Vice President - Compliance
Chief Operating Officer, Senior Vice President - Compliance
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Adam S. Grossman
Mr. Adam S. Grossman
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
3.74M
-0.16%
Dr. Jerrold B. Grossman
Dr. Jerrold B. Grossman
Vice Chairman of the Board, Co-Founder
Vice Chairman of the Board, Co-Founder
570.90K
--
Mr. Brad L. Tade
Mr. Brad L. Tade
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
258.17K
-2.68%
Mr. Lawrence P. Guiheen
Mr. Lawrence P. Guiheen
Independent Director
Independent Director
145.83K
-12.06%
Mr. Steven A. (Steve) Elms
Mr. Steven A. (Steve) Elms
Independent Chairman of the Board
Independent Chairman of the Board
87.33K
--
Mr. Eduardo Rene Salas
Mr. Eduardo Rene Salas
Independent Director
Independent Director
10.89K
--
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
暂无数据
地区USD
名称
营收
占比
United States
121.98M
0.00%
International
0.00
0.00%
业务
地区
暂无数据
股东统计
更新时间: 10月24日 周五
更新时间: 10月24日 周五
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
14.01%
The Vanguard Group, Inc.
8.79%
State Street Investment Management (US)
5.08%
Invesco Advisers, Inc.
4.28%
Geode Capital Management, L.L.C.
2.48%
其他
65.35%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
14.01%
The Vanguard Group, Inc.
8.79%
State Street Investment Management (US)
5.08%
Invesco Advisers, Inc.
4.28%
Geode Capital Management, L.L.C.
2.48%
其他
65.35%
股东类型
持股股东
占比
Investment Advisor
50.09%
Investment Advisor/Hedge Fund
29.08%
Hedge Fund
5.68%
Individual Investor
2.56%
Research Firm
2.01%
Private Equity
1.44%
Pension Fund
1.21%
Bank and Trust
0.44%
Venture Capital
0.24%
其他
7.26%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
724
215.13M
90.39%
-25.52M
2025Q2
680
225.21M
94.37%
-6.16M
2025Q1
658
218.51M
91.53%
-12.93M
2024Q4
607
216.39M
91.46%
-18.31M
2024Q3
547
221.08M
93.58%
+11.33M
2024Q2
451
193.54M
83.08%
-7.68M
2024Q1
408
187.57M
81.05%
-5.26M
2023Q4
371
181.77M
80.46%
-8.48M
2023Q3
362
185.07M
81.97%
+86.17K
2023Q2
349
179.85M
80.15%
-7.63M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
33.35M
13.98%
-846.07K
-2.47%
Jun 30, 2025
The Vanguard Group, Inc.
21.31M
8.93%
+4.52M
+26.94%
Jun 30, 2025
State Street Investment Management (US)
12.08M
5.06%
+637.73K
+5.57%
Jun 30, 2025
Invesco Advisers, Inc.
10.20M
4.27%
+508.12K
+5.24%
Jun 30, 2025
Geode Capital Management, L.L.C.
5.91M
2.48%
+245.31K
+4.33%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
4.76M
2%
-97.24K
-2.00%
Jun 30, 2025
American Century Investment Management, Inc.
4.61M
1.93%
+358.63K
+8.43%
Jun 30, 2025
Thrivent Asset Management, LLC
3.32M
1.39%
+1.45M
+78.10%
Jun 30, 2025
Nuveen LLC
4.10M
1.72%
+638.57K
+18.45%
Jun 30, 2025
Grossman (Adam S)
3.75M
1.57%
-6.00K
-0.16%
Sep 15, 2025
查看更多
持股ETF
更新时间: 11月6日 周四
更新时间: 11月6日 周四
机构名称
占比
Invesco S&P SmallCap Health Care ETF
2.22%
SPDR S&P Biotech ETF
1.34%
Harbor Health Care ETF
1.17%
Virtus LifeSci Biotech Products ETF
1.13%
AAM Sawgrass US Small Cap Quality Growth ETF
1.12%
Invesco S&P SmallCap Quality ETF
1.1%
Invesco S&P SmallCap 600 Pure Growth ETF
0.98%
Invesco S&P SmallCap 600 GARP ETF
0.98%
Invesco S&P SmallCap Momentum ETF
0.73%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.73%
查看更多
Invesco S&P SmallCap Health Care ETF
占比2.22%
SPDR S&P Biotech ETF
占比1.34%
Harbor Health Care ETF
占比1.17%
Virtus LifeSci Biotech Products ETF
占比1.13%
AAM Sawgrass US Small Cap Quality Growth ETF
占比1.12%
Invesco S&P SmallCap Quality ETF
占比1.1%
Invesco S&P SmallCap 600 Pure Growth ETF
占比0.98%
Invesco S&P SmallCap 600 GARP ETF
占比0.98%
Invesco S&P SmallCap Momentum ETF
占比0.73%
Pacer US Small Cap Cash Cows Growth Leaders ETF
占比0.73%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
